Unlimited Submissions for NIH Grants?

The National Institutes of Health is weighing a peer-review system where grant proposals, even ones being resubmitted, would be treated as new.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, VIA FLICKR: PEN WAGGENERCurrently researchers seeking funding from the National Institutes of Health (NIH) can resubmit their grant proposals only once after they have been rejected. But that may soon change. In December, the advisory council for NIH's Center for Scientific Review (CSR) floated a plan to let investigators resubmit unsuccessful grant proposals as many times as they want, with reviewers considering them anew each time.

“The CSR council suggested a pilot study in which investigators would be allowed an unlimited number of resubmissions but no more than two applications over 12 months,” according to ScienceInsider.

The idea is not a new one. It was originally proposed in 2008, when an internal NIH report suggested ending the system that allowed researchers to resubmit their grant applications just twice after initial rejection. Instead, the NIH reduced the number of permitted resubmissions to one. Now, as the success rate for NIH proposals hangs at a dismal 18 percent, the agency is looking for a way to reinvigorate the peer-review process.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies